The expression of ARL4C exhibited a significant and positive correlation with immune-related pathways such as TNF-α/NF-κB, INF-γ, INF-α, IL-6/JAK/STAT3, and hypoxia signaling pathways, thereby establishing a connection between ARL4C and tumor immunity. This evidence concerns the gene IFNA17 and neoplasm.